Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi

Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with a forbidden message. This prevents viewing the trial record and related information on the page.
    Difference
    19%
    Check dated 2026-09-23T20:22:58.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a newer version of the page documentation or interface.
    Difference
    0.0%
    Check dated 2026-09-16T22:12:02.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a new revision tag, v3.6.6, replacing the previous v3.6.5. This indicates a minor platform or CMS update and does not alter the study information.
    Difference
    0.0%
    Check dated 2026-09-02T18:21:24.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A new line under Other Study ID Numbers adds a funding note for 2018.
    Difference
    0.0%
    Check dated 2026-08-26T19:50:18.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A plain-language summary of the SAVANNAH study has been added to the Study Details page, outlining the rationale and design of combining osimertinib with savolitinib in EGFRm+/MET+ NSCLC after progression on osimertinib. The previous plain-language summary citation line has been removed/updated to reflect the new entry.
    Difference
    0.0%
    Check dated 2026-08-19T13:00:51.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.5, replacing the previous v3.6.4 tag to reflect a newer version.
    Difference
    0.0%
    Check dated 2026-08-12T04:55:08.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.